BriaCell Therapeutics Corp.

BCTXW · NASDAQ
Analyze with AI
7/31/2025
7/31/2024
7/31/2023
7/31/2022
Operating Activities
Net Income-$27-$5-$20-$27
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$2$2$3
Change in WC-$2$7-$4-$0
Other Non-Cash-$1-$28-$2$12
Operating Cash Flow-$28-$24-$24-$12
Investing Activities
PP&E Inv.$0-$0$0$0
Net Acquisitions$0-$0$0$0
Inv. Purchases-$7$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0$0$0$0
Investing Cash Flow-$8-$1$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$46$4$4$0
Stock Repurch.$0$0-$0-$13
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0$0$6
Financing Cash Flow$45$4$4-$4
Forex Effect$0$0$0$0
Net Chg. in Cash$10-$20-$20-$16
Supplemental Information
Beg. Cash$1$21$41$57
End Cash$10$1$21$41
Free Cash Flow-$28-$25-$24-$12
BriaCell Therapeutics Corp. (BCTXW) Financial Statements & Key Stats | AlphaPilot